Yes. Today, sponsors, pharmaceutical companies, and healthcare innovation companies pay thousands of dollars to access specific patient cohorts. If your institution serves populations with common or rare conditions, your data has enormous economic value . The data assets stored on your servers can become a new source of recurring revenue.

100% secure. With our Federated Computing technology , your data never leaves your servers . No one downloads it, copies it, or buys it. Buyers only have temporary, controlled access, always under your supervision. Your data remains yours.

No. Never. All data access enabled by the ResearchNexo Interface Processor is anonymized, complying with local and international regulations (GDPR, HIPAA, etc.). Your institution maintains complete control over sensitive information.

ResearchNexo is a clinical data marketplace . ResearchNexo brings to your organization eBay-style offers. Price and access control are always yours.

Institutions that provide or manage healthcare services have valuable data assets that can become a new source of income. These institutions include:

• Healthcare Providers who typically manage electronic health records (EHRs), imaging data, prescriptions, and treatment histories.:
  • Hospitals and health systems
  • Clinics and physician practices
  • Specialty centers (oncology, cardiology, dialysis, etc.)
  • Pharmacies and diagnostic labs
• Payers and Insurers who typically manage healthcare claims and billing data, often linked to clinical data:
  • Public insurers
  • Private health insurance companies
  • Employer-sponsored health plans
• Government and Public Health Agencies who commonly oversee population health data, registries, and surveillance:
  • National health authorities
  • Regulators
  • Public health agencies
  • Disease registries (cancer, rare diseases, immunizations)
• Research Institutions like universities and research networks that collect and analyze healthcare data for clinical research and real-world evidence:
  • Academic medical centers
  • Biobanks and genomic data repositories
  • Clinical trial organizations
  • Research consortia
• Technology and Data Infrastructure Providers that store, process, and enable secure sharing of healthcare data:
  • Electronic health record (EHR) vendors
  • Cloud providers
  • Data exchange networks
  • Federated computing platforms like ResearchNexo© (used for privacy-preserving data analysis)

ResearchNexo does the heavy lifting for proactive marketing . Life Sciences and Industry Stakeholders that use healthcare data for R&D, product development, and post-market surveillance access ResearchNexo proprietary Dashboard and are directed to the data assets that fit their search. Your visibility is global from day one.

The value of a data asset is not fixed like physical assets (a building, a machine), but instead depends on its quality, use, and context. In healthcare especially, data is an asset because it can be leveraged for decision-making, innovation, and revenue generation.

ResearchNexo enables participating Members of the Medinexo Network to assure the main dimensions of a data asset’s value:

• Intrinsic Value of the Data
  • Quality: Accuracy, completeness, consistency, timeliness.
  • Uniqueness: Rare or hard-to-replicate datasets (e.g., longitudinal patient data, rare disease cohorts).
  • Granularity: Level of detail (e.g., raw clinical notes vs. aggregated claims).
  • Scale: Size and diversity of the population covered.
• Utility / Use Value
  • Clinical use: Improves patient care, safety, diagnostics, and outcomes.
  • Operational use: Reduces costs, improves efficiency in healthcare delivery.
  • Research value: Enables clinical trials, epidemiology, drug development, and real-world evidence.
  • Business value: Supports product development, market access, pricing, and regulatory approval.
• Market Value
  • Demand: Pharmaceutical companies, insurers, researchers, and policymakers may pay for access.
  • Regulatory approval: Data that supports regulatory submissions has high value.
  • Licensing & monetization: Some institutions sell or license anonymized datasets.
• Strategic Value
  • Competitive advantage: Exclusive data can differentiate a company in R&D or healthcare services.
  • Partnerships: Data enables collaborations between providers, payers, life sciences, and tech vendors.
  • Network effects: The more an asset is linked with other datasets (e.g., genomic + clinical + claims), the more valuable it becomes.
• Compliance & Risk Considerations (negative value if mishandled)
  • Regulatory compliance: Must adhere to HIPAA, GDPR, etc.
  • Security: Breaches reduce trust and financial value.
  • Ethical use: Misuse or bias can damage reputation and limit usability.

Very little. ResearchNexo activation is fast: within days, you can be on the global marketplace and receive access requests to your data.

Your Medinexo Prime Site Membership includes a ResearchNexo Interface Processor that put your institution on the map. For only $99 USD per month. That’s less than the price of a private consultation. In return, you become part of the most dynamic global Real World Evidence Market there is, ResearchNexo©.

No. Access is temporary, traceable, and secure. The Life Sciences and Industry Stakeholders who license access to your data assets are limited to the access to only the specific data asset you licensed over the period of time of your Data Asset Access Agreement specified. You decide what type of data access is enabled and under what conditions. Your data never changes hands.

Yes. It’s a flexible subscription. There are no long-term contracts or hidden penalties.

No. ResearchNexo provides the technology.

Most platforms buy and resell data . We don’t. With ResearchNexo©, you remain the owner . The difference is monumental:

• More control.
• More security.
• More revenues.

Today, more than 1,800 sites in 35+ countries are connected to the Medinexo® Network, and hundreds of sponsors seek clinical data using their ResearchNexo Dashboard. From day one, your data has global visibility to active buyers.

Legally and ethically, the original owner of the data is always the patient .
However, the patient entrusts that data to the hospital, clinic, or research center for their medical care or participation in a study.
In reality:

• The hospital or site is the custodian of that data and is responsible for storing, protecting, and using it in accordance with the law.
  
  
• The patient retains the right to the ethical and safe use of his or her information.
  
  
• ResearchNexo does not own any data ; it provides the Federated computing platforms (used for privacy-preserving data analysis) that allows hospitals to monetize access in an anonymous and secure manner , while maintaining local control of the information.
  
  

In short:
👉 The patient is the original owner of the information.
👉 The hospital or site is the custodian and can decide, subject to regulatory compliance, how access to that data is provided.
👉 Medinexo only connects and facilitates access under a technological model that guarantees that the data is never transferred or sold , but remains under the control of the site.